Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07486934
PHASE3

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

Sponsor: Dyne Therapeutics

View on ClinicalTrials.gov

Summary

The purpose of the study is to assess the efficacy, safety, and tolerability of zeleciment basivarsen (DYNE-101) for the treatment of myotonic dystrophy 1 (DM1).

Official title: A Phase 3, Randomized, Double-Blind, 48-Week Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2026-05-14

Completion Date

2029-01

Last Updated

2026-07-14

Healthy Volunteers

No

Interventions

DRUG

zeleciment basivarsen (DYNE-101)

Administered by IV infusion

DRUG

Placebo

Administered by IV infusion

Locations (18)

UCSD - Altman Clinical and Translational Research Institute

La Jolla, California, United States

Rare Disease Research, LLC

Atlanta, Georgia, United States

IU Health Neuroscience Center

Indianapolis, Indiana, United States

Roy Blunt NextGen Precision Health Institute

Columbia, Missouri, United States

Rare Disease Research, LLC

Hillsborough, North Carolina, United States

The University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

UZ Leuven

Leuven, Belgium

Rigshospitalet, (Neuromuscular Clinic and Research Unit, Department 8077)

Copenhagen, Denmark

CHU de Nantes - Hôtel-Dieu

Nantes, France

Pitié-Salpêtrière Hospital

Paris, France

CHU de Toulouse - Hôpital Pierre-Paul Riquet

Toulouse, France

LMU Klinikum der Universität München Neurologische Klinik und Poliklinik Friedrich-Baur-Institut Campus Innenstadt

Munich, Bavaria, Germany

Charité Universitätsmedizin Berlin Campus-Buch Muscle Research Unit

Berlin, State of Berlin, Germany

Centro Clinico Nemo Milano, Fondazione Serena ETS

Milan, Milano, Italy

National Hospital Organization Osaka Toneyama Medical Center

Toyonaka-Shi, Osaka, Japan

Yamaguchi University Hospital

Ube-Shi, Yamaguchi, Japan

Hospital Universitario Infanta Sofía

San Sebastián de los Reyes, Madrid, Spain

University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery

London, England, United Kingdom